Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Ultrasound Device for Evaluating Bone Strength Approved

Ultrasound Device for Evaluating Bone Strength Approved The FDA has approved an ultrasound device (Sahara Clinical Bone Sonometer, Hologic, Inc, Waltham, Mass) for use in conjunction with assessment of other clinical risk factors to aid in the diagnosis of osteoporosis and estimation of fracture risk. The portable device transmits sound waves through the patient's heel and measures the speed and attenuation of sound through bone. Studies have shown that measurements obtained with this device are as good as bone mineral x-ray densitometry measurements in assessing a patient's bone fracture risk. The essential prescribing information (labeling) for the product warns that the "Individualization of Treatment" and "Relationship Between Sahara Results and Bone Mineral Density Results Obtained by X-ray Densitometry" sections must be read to properly interpret results. It states that the results obtained with the sonometer may be used, along with other factors such as laboratory test results, radiographs, and family history, in the diagnosis of osteoporosis and estimation of fracture risk. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Ultrasound Device for Evaluating Bone Strength Approved

JAMA , Volume 279 (17) – May 6, 1998

Ultrasound Device for Evaluating Bone Strength Approved

Abstract

The FDA has approved an ultrasound device (Sahara Clinical Bone Sonometer, Hologic, Inc, Waltham, Mass) for use in conjunction with assessment of other clinical risk factors to aid in the diagnosis of osteoporosis and estimation of fracture risk. The portable device transmits sound waves through the patient's heel and measures the speed and attenuation of sound through bone. Studies have shown that measurements obtained with this device are as good as bone mineral x-ray densitometry...
Loading next page...
 
/lp/american-medical-association/ultrasound-device-for-evaluating-bone-strength-approved-FpmMQqUZsS
Publisher
American Medical Association
Copyright
Copyright © 1998 American Medical Association. All Rights Reserved.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.279.17.1339-JFD80003-2-1
Publisher site
See Article on Publisher Site

Abstract

The FDA has approved an ultrasound device (Sahara Clinical Bone Sonometer, Hologic, Inc, Waltham, Mass) for use in conjunction with assessment of other clinical risk factors to aid in the diagnosis of osteoporosis and estimation of fracture risk. The portable device transmits sound waves through the patient's heel and measures the speed and attenuation of sound through bone. Studies have shown that measurements obtained with this device are as good as bone mineral x-ray densitometry measurements in assessing a patient's bone fracture risk. The essential prescribing information (labeling) for the product warns that the "Individualization of Treatment" and "Relationship Between Sahara Results and Bone Mineral Density Results Obtained by X-ray Densitometry" sections must be read to properly interpret results. It states that the results obtained with the sonometer may be used, along with other factors such as laboratory test results, radiographs, and family history, in the diagnosis of osteoporosis and estimation of fracture risk.

Journal

JAMAAmerican Medical Association

Published: May 6, 1998

Keywords: ultrasonography,medical devices

There are no references for this article.